Impact of epidemiological and nutritional factors on outcomes following traumatic brain injury in a prospective cohort study Authors: Elham Afsar, Homayoun Sadeghi-Bazargani, Firooz Salehpour, Alireza Bihamta, Sarvin Sanaie, Mehmet Tatli, Hassan Soleimanpour Published: 2026 ABSTRACT Traumatic brain injury (TBI) continues to be one of the world’s top causes of mortality and long-term disability. It is a severe and frequently fatal disorder. Patients with traumatic brain injury (TBI) not only sustain neurological impairment but also undergo significant metabolic changes and psychological stress, which may affect their ability to recover. The purpose of this study was to investigate the nutritional determinants and epidemiological trends linked to outcomes in traumatic brain injury patients. This prospective cohort study was carried out at the Imam Reza Hospital’s Trauma Department in Tabriz, Iran. Over the course of six months, 520 patients with moderate-to-severe traumatic brain injury were consecutively enrolled, and they were monitored for one month following their release from the hospital. Clinical findings, radiographic results, laboratory data, therapies, outcomes, mechanisms of injury, and demographics were all methodically documented. BMI and serum albumin levels were used at discharge and one-month follow-up to evaluate nutritional status. The Impact of Event Scale (IES) and the Hospital Anxiety and Depression Scale (HADS) were used to assess psychological status. Descriptive techniques, correlation analyses, paired comparisons, and receiver operating characteristic (ROC) curve analysis were among the statistical techniques used to evaluate the standalone discriminatory ability of psychological and nutritional variables. The mean age of the patients was 32.49 ± 13.78 years, and 71.7% were male. Nearly 75% of injuries were caused by falls, making them the most frequent cause. In total, 51.2% of patients passed away while in the hospital, whereas 48.8% of patients survived discharge. Discharge and one-month Glasgow Coma Scale (GCS) scores demonstrated a substantial correlation with outcome (p < 0.001), and neurological severity was strongly associated with survival. Survival, neurological improvement, and psychological distress did not significantly correlate with either discharge or follow-up BMI. Additionally, there was no significant correlation between serum albumin levels and survival, anxiety, depression, or symptoms of post-traumatic stress disorder. BMI, HADS, and IES all showed poor outcome discrimination, and ROC analyses supported their limited standalone discriminatory ability. In this cohort of patients with moderate-to-severe TBI, BMI and serum albumin were not associated with survival or psychological distress and showed limited standalone discriminatory ability for short-term outcomes. These findings suggest that recovery after TBI cannot be adequately characterized by simple nutritional indices alone and support the use of more comprehensive, multidimensional approaches to nutritional and prognostic assessment in TBI survivors. Introduction Traumatic brain injury (TBI) is a group of injuries that result from severe head trauma and can result in varying degrees of paralysis, loss of consciousness, amnesia, and even death1. Head trauma accounts for the majority of deaths from concussions2. Symptoms of this type of injury can manifest as physical, sensory, motor, behavioral, and psychological symptoms3. TBI doesn’t only affect the individual; it also has a profound impact on families and communities creating a financial burden4. For those who survive, TBI can result in prolonged physical, neurological, and psychological impairments, with about half of the affected individuals experiencing moderate to severe long-term disabilities5. TBI also imposes a substantial economic burden, which has been reported to be comparable to the combined costs of cardiovascular disease, cancer, and diabetes6. According to previous studies, TBI is the leading cause of death or disability in people under 45 years of age7. Falls and motor vehicle accidents are the main causes of TBI8,9. Differences in outcomes after TBI were reported to be associated with age, with outcomes worsening as early as age 4510,11. In addition, while patients 65 years and older only account for 15% of the population, they make up 50% of TBI-related deaths12. Moreover, TBI has more prevalence in male compared to female populations. However, female populations suffer more from TBI related mortality and severity13. In a recent study by Kennedy et al. gender was shown to have no value in predicting 6-month outcomes after moderate or severe blunt pediatric TBI. Also they reported that neonates had a higher mortality rate than older children and adolescents. And Glasgow Coma Scale (GCS) outperformed other clinical and imaging predictors and strongly correlates with 6-month outcomes in children and adolescents with moderate and severe head injury14. Although the prognostic value of simple nutritional indices remains uncertain, previous studies have reported inconsistent associations between body mass index and TBI outcomes, and few prospective studies have simultaneously examined survival and short-term psychological outcomes using both anthropometric and biochemical nutritional markers. Therefore, this prospective cohort study aimed to assess the epidemiological characteristics of moderate-to-severe traumatic brain injury and to determine whether BMI and serum albumin were associated with short-term survival and psychological distress after discharge. Materials and methods Study design The purpose of this prospective, non-interventional cohort study was to identify the nutritional variables and epidemiological patterns affecting clinical outcomes in TBI patients. The study was conducted at Imam Reza Hospital’s Trauma Department in Tabriz, Iran, a significant tertiary referral facility for trauma care in the area. The entire experiment, including post-discharge follow-up, took about twelve months to complete. Patient recruitment was completed consecutively over a period of six months. Inclusion criteria included patients with moderate-to-severe TBI admitted to the trauma department who provided informed consent, either directly or through their legal guardians. Exclusion criteria included patients with pre-existing central nervous system disorders, those with unclear mechanisms of injury, patients whose initial injury was extra-cranial, and cases with incomplete or missing medical records. Nutritional assessment rationale BMI and serum albumin were selected because they are routinely available, low-cost indicators that can be obtained in standard trauma care settings. These markers were chosen to evaluate whether commonly used bedside nutritional indices have prognostic utility in this population. However, we acknowledge that they do not fully reflect body composition, nitrogen balance, sarcopenia, or acute metabolic stress. Sample size The target sample size was determined based on prior studies reporting an approximately 42% mortality rate in traumatic brain injury, assuming a 95% confidence level and a 4% margin of error, with an additional allowance for incomplete data and follow-up losses. During the study period, all consecutively eligible patients were enrolled, resulting in a final sample of 520 participants. Data collection procedure Patient information was collected in two phases. The first phase corresponded to the period of initial hospitalization, during which baseline characteristics and daily clinical, laboratory, and therapeutic data were recorded. The second phase consisted of a post-discharge follow-up, in which patients were contacted by telephone one month after discharge and follow-up outcome data were obtained. One-month follow-up assessments were conducted by trained study personnel through structured telephone interviews. Psychological outcomes were assessed using interviewer-administrated versions of the Hospital Anxiety and Depression Scale (HADS) and the Impact of Event Scale (IES). All hospital survivors were targeted for follow-up at the predefined one-month interval; survival status was confirmed for contacted participants, and psychological assessments were completed only when the patient was able to respond. During hospitalization, demographic characteristics, mechanism of injury, neurological status, radiological findings, laboratory values, treatments, feeding status, and discharge outcomes were systematically recorded. Nutritional assessment included BMI and serum albumin at discharge and again at one month after discharge (Table 1,2,3,4). Statistical analysis Frequency and percentage were used to characterize qualitative data, whereas mean ± standard deviation was used to summarize quantitative variables. Kurtosis and skewness criteria were used to evaluate normality. Paired tests were used to compare repeated measurements, and correlation analysis was used as needed to look at relationships between neurological measures, psychological ratings, and nutritional markers. The independent discriminatory power of BMI and psychological variables in relation to outcome was assessed using receiver operating characteristic (ROC) curve analysis. The area under the curve (AUC) and 95% confidence intervals were calculated for each variable; an AUC value near 0.50 was regarded as indicating no substantial discriminatory capacity. Statistical analyses were performed using SPSS software, and p-values below 0.05 were considered statistically significant. Statistical analyses were performed using IBM SPSS Statistics for Windows, Version 27.0 (IBM Corp., Armonk, NY, USA). Available at: https://www.ibm.com/products/spss-statistics. Missing data handling Analyses were conducted using available data. Patients with incomplete baseline medical records were excluded according to the study criteria. For follow-up variables, available-case analysis was used; therefore, one-month psychological and laboratory assessments were analyzed only among participants with available follow-up data. Ethical considerations The study protocol was approved by the Ethics Committee of Tabriz University of Medical Sciences (Ethics code: IR.TBZMED.REC.1402.715). Written informed consent was obtained from all participants or their legal guardians. All methods were performed in accordance with the relevant guidelines and regulations. Results A total of 520 TBI patients were enrolled in this study. The mean age of participants was 32.49 ± 13.78 years, ranging from 1 to 70 years, and 71.7% of them were males. The majority of participants (52.3%) were single. Moreover, 42.7% of the patients held a diploma, 29.2% had college education, and 18.3% were illiterate. In terms of TBI mechanisms, falls were the most common mechanism of injury, accounting for 72.5% of cases, followed by road traffic accidents (22.3%) and interpersonal violence (5.2%). As for triage classes, most of the patients (81.3%) were classified as Triage Level II, while 18.7% were Level I. Clinical symptoms at presentation included headache in 88.7% of patients, loss of consciousness in 60.0%, disorientation in 46.5%, and seizures in 21.0%. Pupillary examination revealed miosis in 85.4% of the sample. Radiological findings demonstrated a high prevalence of intracranial injuries, including diffuse axonal injury (20.6%), epidural hematoma (20.6%), subdural hematoma (19.6%), contusion (19.4%), intra-ventricular hemorrhage (19.0%), and subarachnoid hemorrhage (17.9%). Airway management was required for approximately half of the patients, with 50.4% undergoing intubation. Baseline blood pressure averaged 87.19 ± 5.71 mmHg, increasing slightly to 87.98 ± 7.50 mmHg at one-month follow-up (p-value = 0.055). Body mass index (BMI) increased significantly from 23.73 ± 2.85 at discharge (Stage 1) to 24.12 ± 3.06 at one month (Stage 2) (p-value = 0.040). Psychological scores, however, did not demonstrate significant changes: HADS increased from 6.76 ± 5.09 to 7.27 ± 5.47 (p-value = 0.516), and IES rose from 15.86 ± 17.56 to 18.28 ± 18.74 (p-value = 0.183). Laboratory markers remained stable, with no statistically significant changes in white blood cell count, hemoglobin, platelet count, creatinine, or albumin between discharge and one-month follow-up. These findings indicate stable physiological status among survivors during recovery. Of the total cohort, 254 patients (48.8%) survived to discharge, while 266 (51.2%) died during hospitalization. Mortality in this study refers to in-hospital mortality during index admission; deaths after discharge were not included in the mortality outcome. Survival was strongly associated with neurological status: both discharge Glasgow Coma Scale (GCS) (χ² = 494.44, p < 0.001) and one-month GCS (χ² = 486.12, p < 0.001) were strongly associated with outcome. Triage level and specific radiological findings, such as subarachnoid hemorrhage, did not demonstrate significant associations with survival. Correlation analyses revealed no clinically meaningful associations between nutritional indicators and neurological recovery. Although BMI1 displayed a very weak negative correlation with GCS1 (r = − 0.088, p = 0.045), BMI2 was not associated with GCS2. Psychological measures (HADS and IES) were also not significantly correlated with GCS at any stage (p > 0.05). Longitudinal comparisons using paired t-tests showed that BMI increased modestly over the recovery period, while vital signs, GCS scores, psychological scores, and laboratory values remained stable between discharge and one month. These findings suggest that although slight improvements in nutritional status occurred, neurological severity remained the primary determinant of outcome among TBI survivors. Medication and supportive treatment During hospitalization, a variety of drugs, hemodynamic agents, anticonvulsants, anticoagulants, and nutritional/feeding therapies were used. While some therapies were performed judiciously based on clinical severity and treatment protocols, the majority of patients required supporting medical therapy. A small percentage of patients received vasoactive medications, such as dobutamine (19.2%), norepinephrine (17.3%), and epinephrine (17.9%). Anticonvulsant medication was widely used; 20.6% of patients received phenytoin, and all patients received levetiracetam in accordance with the institutional policy. Citicoline (59.6%), nimodipine (51.2%), amantadine (16.7%), and L-carnitine (18.1%) were among the neuroprotective or adjunctive drugs. Anticoagulation and blood products were administered selectively: 16.9% of patients received enoxaparin, 79.8% received heparin, 20.2% received fresh frozen plasma, 21.3% received platelets, and 21.0% received packed cells. Nutrition and feeding status Feeding status varied across the sample. PO tolerance was observed in 20.6% of patients; 21.2% of the patients were NPO, 18.5% received a regular diet, 21.1% received a liquid diet and 18.5% were fed with gavage formula. There were no clinically significant correlations between nutritional markers and survival or psychiatric outcomes, according to correlation analyses (Tables 5 and 6). While follow-up BMI measurements did not substantially correlate with GCS2, baseline BMI did exhibit a very slight negative connection with GCS1 (r = − 0.088, p = 0.045). Furthermore, there was no significant correlation seen between baseline or follow-up BMI and HADS, IES, or outcome status. Similarly, there was no significant correlation seen between serum albumin levels at baseline and follow-up and outcomes, trauma-related stress symptoms, or anxiety/depression symptoms. Overall, these results show that in this population, there were only weak correlations between BMI and albumin and short-term neurological, psychosocial, and survival outcomes. Table 1Demographic and clinical characteristics.VariableCategory/Mean ± SDn (%)Age (years)32.49 ± 13.78SexMale373 (71.7)Female147 (28.3)Marital statusSingle272 (52.3)Married248 (47.7)Educational levelDiploma222 (42.7)College152 (29.2)Injury mechanismFalls377 (72.5%)Road traffic accident116 (22.3%)Interpersonal violence27 (5.2%)Triage levelI97 (18.7%)II423 (81.3%) Table 1Demographic and clinical characteristics.VariableCategory/Mean ± SDn (%)Age (years)32.49 ± 13.78SexMale373 (71.7)Female147 (28.3)Marital statusSingle272 (52.3)Married248 (47.7)Educational levelDiploma222 (42.7)College152 (29.2)Injury mechanismFalls377 (72.5%)Road traffic accident116 (22.3%)Interpersonal violence27 (5.2%)Triage levelI97 (18.7%)II423 (81.3%) Demographic and clinical characteristics. Table 2Nutritional and psychological measures.Variable N Mean ± SDBMI152023.73 ± 2.85BMI252024.12 ± 3.06HADS15206.76 ± 5.09HADS22547.27 ± 5.47IES152015.86 ± 17.56IES225418.28 ± 18.74BMI: Body mass index, HADS: Hospital anxiety and depression scale, IES: Impact of event scale. Table 2Nutritional and psychological measures.Variable N Mean ± SDBMI152023.73 ± 2.85BMI252024.12 ± 3.06HADS15206.76 ± 5.09HADS22547.27 ± 5.47IES152015.86 ± 17.56IES225418.28 ± 18.74BMI: Body mass index, HADS: Hospital anxiety and depression scale, IES: Impact of event scale. Nutritional and psychological measures. BMI: Body mass index, HADS: Hospital anxiety and depression scale, IES: Impact of event scale. Table 3Laboratory values at stage 1 and stage 2.Laboratory markerStage 1 Mean ± SDStage 2 Mean ± SDp-valueWBC7.99 ± 2.018.11 ± 1.970.315Hemoglobin13.49 ± 1.4713.59 ± 1.530.290Platelets250.64 ± 49.40248.57 ± 50.940.497Creatinine0.987 ± 0.280.999 ± 0.290.504Albumin3.979 ± 0.503.991 ± 0.510.698 Table 3Laboratory values at stage 1 and stage 2.Laboratory markerStage 1 Mean ± SDStage 2 Mean ± SDp-valueWBC7.99 ± 2.018.11 ± 1.970.315Hemoglobin13.49 ± 1.4713.59 ± 1.530.290Platelets250.64 ± 49.40248.57 ± 50.940.497Creatinine0.987 ± 0.280.999 ± 0.290.504Albumin3.979 ± 0.503.991 ± 0.510.698 Laboratory values at stage 1 and stage 2. Table 4Medications and supportive treatments.Medicationn (%)Epinephrine93 (17.9%)Norepinephrine90 (17.3%)Dobutamine100 (19.2%)Phenytoin107 (20.6%)Tranexamic acid101 (19.4%)Antibiotic519 (99.8%)Sedative82 (15.8%)Corticosteroid516 (99.2%)NaCl hypertonic %5107 (20.6%)Furosemide112 (21.5%)Mannitol101 (19.4%)L-carnitine94 (18.1%)Amantadine87 (16.7%)Citicoline310 (59.6%)Nimodipine266 (51.2%)Magnesium sulfate105 (20.2%)Enoxaparin88 (16.9%)FFP105 (20.2%)Heparin415 (79.8%)Platelets111 (21.3%)Packed cells109 (21.0%)PO tolerance107 (20.6%)NPO110 (21.2%)Regular diet96 (18.5%)Liquid diet110 (21.2%)Gavage formula96 (18.5%)FFP: Fresh frozen plasma, NPO: Nil Per Os, PO: Per Os. Table 4Medications and supportive treatments.Medicationn (%)Epinephrine93 (17.9%)Norepinephrine90 (17.3%)Dobutamine100 (19.2%)Phenytoin107 (20.6%)Tranexamic acid101 (19.4%)Antibiotic519 (99.8%)Sedative82 (15.8%)Corticosteroid516 (99.2%)NaCl hypertonic %5107 (20.6%)Furosemide112 (21.5%)Mannitol101 (19.4%)L-carnitine94 (18.1%)Amantadine87 (16.7%)Citicoline310 (59.6%)Nimodipine266 (51.2%)Magnesium sulfate105 (20.2%)Enoxaparin88 (16.9%)FFP105 (20.2%)Heparin415 (79.8%)Platelets111 (21.3%)Packed cells109 (21.0%)PO tolerance107 (20.6%)NPO110 (21.2%)Regular diet96 (18.5%)Liquid diet110 (21.2%)Gavage formula96 (18.5%)FFP: Fresh frozen plasma, NPO: Nil Per Os, PO: Per Os. Medications and supportive treatments. FFP: Fresh frozen plasma, NPO: Nil Per Os, PO: Per Os. Table 5Correlation between nutritional indicators and GCS.Variables r p-valueBMI1 and GCS1−0.0880.045BMI2 and GCS2−0.0620.159BMI3 and GCS20.0970.122BMI: Body mass index, GCS: Glasgow coma scale. Table 5Correlation between nutritional indicators and GCS.Variables r p-valueBMI1 and GCS1−0.0880.045BMI2 and GCS2−0.0620.159BMI3 and GCS20.0970.122BMI: Body mass index, GCS: Glasgow coma scale. Correlation between nutritional indicators and GCS. BMI: Body mass index, GCS: Glasgow coma scale. Table 6Correlation between BMI, psychological indicators, and outcome.VariablesCorrelation (r)p-valueBMI1 and HADS10.0110.797BMI1 and IES10.0110.805BMI2 and HADS20.0780.215BMI2 and IES2−0.0660.297BMI1 and Outcome−0.0160.720BMI2 and Outcome−0.0620.159Albumin1 and HADS1−0.0370.395Albumin2 and HADS20.0030.966Albumin1 and IES10.0150.740Albumin2 and IES2−0.0280.657Albumin1 and outcomes−0.0440.313Albumin2 and outcomes0.0420.337BMI: Body mass index, HADS: Hospital anxiety and depression scale, IES: Impact of event scale. Table 6Correlation between BMI, psychological indicators, and outcome.VariablesCorrelation (r)p-valueBMI1 and HADS10.0110.797BMI1 and IES10.0110.805BMI2 and HADS20.0780.215BMI2 and IES2−0.0660.297BMI1 and Outcome−0.0160.720BMI2 and Outcome−0.0620.159Albumin1 and HADS1−0.0370.395Albumin2 and HADS20.0030.966Albumin1 and IES10.0150.740Albumin2 and IES2−0.0280.657Albumin1 and outcomes−0.0440.313Albumin2 and outcomes0.0420.337BMI: Body mass index, HADS: Hospital anxiety and depression scale, IES: Impact of event scale. Correlation between BMI, psychological indicators, and outcome. BMI: Body mass index, HADS: Hospital anxiety and depression scale, IES: Impact of event scale. Predictive performance of nutritional and psychological indicators for outcome ROC curve analysis was used to assess standalone discriminatory ability of nutritional and psychological indicators in relation to outcome. Overall, the results showed limited discriminatory ability across all examined variables. Figure.1 shows the ROC curve for BMI in relation to patients outcome. Discharge BMI demonstrated an AUC of 0.51, indicating no meaningful discrimination beyond chance. Similarly, psychological measures showed poor standalone discrimination. Figure.2 shows the ROC curve of HADS, and Figure.3 shows the ROC curve for IES. The AUC values for HADS and IES were 0.52 and 0.51, respectively, indicating minimal ability to discriminate patient outcomes. Taken together, these ROC analyses indicate that neither BMI nor psychological symptom scores alone had useful standalone discriminatory ability for outcome in this cohort. Discussion In this prospective cohort study, a total of 520 patients with traumatic brain injury (TBI) were enrolled. The mean age of participants was 32.49 ± 13.78 years and the majority were males (71.7%). Falls were the most common cause of TBI, accounting for 72.5% of cases. Overall, 48.8% of patients survived to discharge, whereas 51.2% died during hospitalization. According to our aims, we examined whether nutritional status at discharge and during early post-discharge follow-up was associated with outcomes (including psychological distress, using the Hospital Anxiety and Depression Scale (HADS) and the Impact of Event Scale (IES) as well as survival outcomes). Our findings consistently showed no statistically significant relationships between BMI and HADS at discharge, BMI and IES at discharge, BMI and HADS at follow-up, BMI and IES at follow-up, or BMI at either stage with patient outcome. These results suggest that BMI, alone, may not be a sensitive or clinically meaningful nutritional predictor of psychological outcomes or survival in TBI, especially when measured at discharge or short-term follow-up. Additionally, psychological distress levels (both HADS and IES measures) appeared to be independent of BMI-related variations, highlighting that post-TBI emotional and trauma-related responses may be driven more by injury severity, cognitive impairment, disability, and social/environmental factors rather than by nutritional indicators. These findings contribute to the existing literature by clarifying that although nutrition is a critical component of TBI recovery, BMI in isolation may be insufficient to capture the complexity of metabolic, inflammatory, and psychological pathways after brain injury. Patients with moderate-to-severe traumatic brain injury are particularly vulnerable to the restrictions of BMI. BMI is insensitive to skeletal muscle loss, hypercatabolism, and changes in body composition that often follow severe injury. It also fails to distinguish between fat and lean mass and does not record acute fluid shifts. Edema, resuscitation, immobility, and inflammation can all change body weight in neurocritical care situations without accurately representing nutritional reserve. Therefore, more accurate measurements such as bioelectrical impedance analysis, fat-free mass indices, indirect calorimetry, nitrogen balance, serial dietary/protein intake measurements, or multimarker nutritional panels should be included in future research. TBI is characterized by significant metabolic alterations, including hypermetabolism and hypercatabolism, which increase energy and protein requirements by 40–200% above basal needs15,16. The previous studies show that inadequate nutrition in the acute phase contributes to immune dysfunction, muscle wasting, and impaired neurological recovery17,18. Because of these metabolic changes, body weight and BMI may not reliably reflect true nutritional reserves following TBI. Inflammatory pathways after brain injury can lead to rapid changes in fluid status, lean body mass, and fat distribution, which further interfere with BMI accuracy as a nutritional index19. The results of different studies have argued that body composition techniques, such as bioelectrical impedance analysis (BIA), fat-free mass index (FFMI), phase angle, and nitrogen balance measurement, are more reliable indicators than weight or BMI in TBI populations20. Considering this physiological background, it becomes plausible that the lack of association between BMI and psychological or survival outcomes in the present study may originate from the inability of BMI to reflect key metabolic abnormalities in these patients. Several studies emphasize that nutrition influences outcomes after TBI, although the mechanisms appear to depend on timing, type of nutritional support, and injury severity, not necessarily BMI. For example, early enteral nutrition (< 72 h from injury) has been shown to reduce infections, mortality, and hospital length of stay21–23. Furthermore, adequate protein intake (1.5 to 2.5 g/kg/day) has been associated with improved nitrogen balance, reduced catabolism, and improved outcomes24. A systematic review by Wang et al. found evidence supporting early caloric and protein supplementation, but concluded that BMI had inconsistent associations with TBI outcomes22. Similar findings were noted by Majadan et al., where admission BMI had no significant association with mortality or neurological recovery in severe TBI patients25. These studies align with our results, suggesting that BMI is not an independent predictor of survival or psychological recovery. In contrast, some research has suggested that BMI, particularly obesity, may influence TBI outcomes. A study of mild TBI patients reported that obesity was associated with slower symptom resolution and prolonged recovery26. Another study found that obesity was linked to poorer Glasgow Outcome Scale (GOS) scores at 6 months27. Several factors could explain these contrasting findings. Most studies linking BMI to poor TBI outcomes included mild injuries or mixed severities26,27, whereas BMI may be a weaker predictor in more severe injuries, where pathophysiology is dominated by intracranial pressure elevation, axonal injury, and metabolic dysfunction. Timing of BMI measurement may also explain these differences. Some studies measured BMI at admission, whereas our study assessed BMI at discharge and at one month after discharge. BMI measured at later stages may be less reflective of the initial metabolic insult or nutritional risk. The confounding factors associating with BMI can also clarify the diversity of our findings with other studies. Obesity is usually associated with systemic inflammation, sleep disturbances, cardiovascular comorbidities and impaired glucose tolerance28,29. These comorbidities may worsen outcomes in TBI populations. Collectively, these factors may explain why BMI was not a significant predictor of outcome in our study, whereas some prior studies observed weak associations. The null results found in this study could be explained by several variables. First, the metabolic, inflammatory, and catabolic abnormalities that define traumatic brain injury may not be reflected by BMI and albumin, which are somewhat imprecise indicators. Second, because discharge and one-month evaluations can miss the peak biological changes most important to prognosis, the timing of the measurement may have decreased sensitivity. Third, neurological injury severity has a considerable influence on short-term outcomes in moderate-to-severe traumatic brain injury (TBI), perhaps overshadowing lesser nutritional effects. Lastly, the study’s capacity to identify minute but clinically insignificant correlations may have been diminished if the sample exhibited little variation in BMI and albumin. To the best of our knowledge, few studies have directly examined the impact of BMI in predicting depression, anxiety, or trauma-related symptoms after TBI. Ponsford et al. reported that psychological distress after TBI is strongly associated with injury severity, cognitive impairment, premorbid psychiatric conditions, and social support, rather than metabolic markers30. The results of Weiss et al.’s study showed that, IES scores were influenced by subjective experiences of trauma, coping mechanisms, and environmental stressors31. In the broader non-TBI literature, obesity has been modestly associated with depression32; however, these findings do not translate consistently into TBI settings due to profound neurological and psychosocial disruptions after injury. Our finding that BMI measured at discharge and one month did not correlate with HADS or IES suggests that psychological distress in TBI is multifactorial, with limited influence from body weight or body mass. Several mechanisms may explain why BMI was unrelated to HADS and IES in our cohort: Cognitive impairment, memory deficits, disability, social isolation, and trauma exposure are key contributors to anxiety and depression after TBI30,33. Inflammation and cytokine activity (e.g., IL-6, TNF-α), which correlate with psychological symptoms in other populations, are poorly captured by BMI34. Psychological recovery after TBI often fluctuates over 3–12 months; a one-month follow-up may be too early to detect nutrition-related differences35. If most patients were within a narrow BMI range, variability may have been insufficient to detect significant associations. Our lack of association between BMI and survival is consistent with multiple studies that also reported no meaningful relationship between BMI and mortality after moderate–severe TBI25,36. Several factors may explain why survival was not associated with BMI in this cohort. Nutritional deterioration may develop after the initial injury processes that determine early mortality, and BMI is also insensitive to micronutrient deficiencies and metabolic disturbances that may influence longer-term recovery. According to the results of our study, serum albumin levels were not significantly associated with psychological distress measured by HADS and IES, nor with TBI patients’ outcome. Although serum albumin is commonly considered a nutritional marker in clinical research, it is now well known that albumin predominantly reflects systemic inflammation and acute-phase physiological responses rather than true nutritional reserves, especially in critically ill patients37. In traumatic brain injury, serum albumin concentrations are influenced by cytokine-mediated suppression of hepatic synthesis, fluid resuscitation, capillary leakage and redistribution during the acute inflammatory response38. Given the mentioned mechanisms, serum albumin may lack sufficient sensitivity to act as an independent predictor of outcome in TBI, especially when assessed at limited time points such as discharge or early follow-up. Accordingly, the absence of a significant association between albumin levels and survival outcome in the present cohort is consistent with evidence indicating that early mortality and discharge status in moderate to severe TBI are primarily determined by neurological injury severity and secondary brain injury processes rather than peripheral nutritional biomarkers39. Our findings demonstrated no significant correlation between serum albumin levels and psychological measures. Systemic inflammatory markers such as serum albumin, particularly during early recovery, are unlikely to capture the complex neuropsychological mechanisms underlying post-TBI emotional distress40. As a result, these considerations help explain why serum albumin did not show a significant association with HADS, IES, or outcome in this study and highlight the limitations of using albumin as a substitute marker for nutritional or psychological risk after TBI. Beyond macroscopic nutritional indices, cellular nutrient-sensing and repair pathways, of which mechanistic target of rapamycin (mTOR) signaling is particularly significant, have a significant impact on post-TBI recovery. To control protein synthesis, autophagy, neuronal survival, axonal remodeling, and neuroplasticity, mTOR combines signals pertaining to energy availability, amino acids, growth factors, inflammation, and cellular stress. Dysregulated mTOR signaling has been connected to neuroinflammation, altered metabolic reprogramming, secondary damage cascades, and compromised repair responses in traumatic brain injury. The failure of basic metrics like BMI and serum albumin to capture the biological processes most important to neural repair may be explained by this mechanistic framework. Therefore, in addition to clinical severity indices and radiological findings, future prognostic studies should consider molecular and metabolic indicators, possibly including mTOR-related pathways41–46. BMI-based measurements and psychological symptom scores exhibited area under the curve (AUC) values of 0.50, indicating minimal standalone discriminating capacity for the research outcome when analyzed separately, according to ROC curve analysis in this study. This result is not surprising in cases of traumatic brain injury, when a variety of interrelated factors, such as neurological severity, intracranial pathology, systemic physiological responses, and treatment-related variables, influence outcomes. Therefore, the near-null AUC values found in this study support the need for multivariable prognostic models that incorporate clinical severity indices, radiological findings, and physiological markers and indicate that nutritional and psychological measures alone are inadequate for outcome stratification in TBI. The fact that the analyses in this study were mostly univariable is a significant drawback. No multivariable predictive model was built to account for important clinical determinants including GCS, radiological severity, ventilatory support, or treatment-related parameters, even though ROC analysis was employed to assess the independent discriminatory performance of BMI and psychological markers. Therefore, rather than serving as a definitive prediction model for TBI outcomes, the current findings should be regarded as evidence of the limited independent value of simple nutritional markers. Our study has several strengths that enhance the validity of the findings. Key aspects of this study are the relatively large sample size (N = 520), the prospective cohort design, the two-stage nutritional evaluation, and the detailed documentation of medical treatments and interventions. We also acknowledge several limitations. First, BMI may not be a suitable stand-alone metric for assessing TBI outcomes because it is a limited nutritional marker. There was no evaluation of more accurate metrics such as dietary intake factors, metabolic biomarkers, and body composition studies. Second, the one-month follow-up time might be insufficient to evaluate the long-term functional, psychosocial, and nutritional effects of traumatic brain injury. Depression, anxiety, trauma-related symptoms, metabolic adaptability, and nutritional recovery may develop over several months rather than only in the early post-discharge phase. As a result, delayed or long-term relationships between nutritional status and recovery may not be captured in this study. To better understand the long-term trajectory of nutritional and psychological outcomes following traumatic brain injury, future longitudinal studies with follow-up at 3, 6, and 12 months are required. Furthermore, functional outcomes like GOSE, FIM, and quality-of-life metrics were excluded, and outcomes were mainly evaluated as in-hospital survival versus death. Conclusion In patients with moderate-to-severe traumatic brain injury, this study identified no significant correlations between BMI at discharge or one month and psychological distress (HADS, IES) or survival outcomes. Additionally, there was no significant correlation seen between serum albumin and psychological distress or outcome. These findings underline the need for multimodal evaluations that incorporate metabolic, psychosocial, and clinical severity aspects when assessing prognosis following traumatic brain injury (TBI) and highlight the limitations of basic nutritional markers in neurological populations. Fig. 1Receiver operating characteristic (ROC) curve for discharge body mass index (BMI) in relation to in-hospital survival status among patients with traumatic brain injury. The area under the curve (AUC) was 0.51, indicating no meaningful standalone discriminatory ability beyond chance. Receiver operating characteristic (ROC) curve for discharge body mass index (BMI) in relation to in-hospital survival status among patients with traumatic brain injury. The area under the curve (AUC) was 0.51, indicating no meaningful standalone discriminatory ability beyond chance. Fig. 2Receiver operating characteristic (ROC) curve for the Hospital Anxiety and Depression Scale (HADS) score in relation to the study outcome. The AUC was 0.52, indicating poor standalone discrimination. Receiver operating characteristic (ROC) curve for the Hospital Anxiety and Depression Scale (HADS) score in relation to the study outcome. The AUC was 0.52, indicating poor standalone discrimination. Fig. 3Receiver operating characteristic (ROC) curve for the Impact of Event Scale (IES) score in relation to the study outcome. The AUC was 0.51, showing minimal standalone discriminatory performance. Receiver operating characteristic (ROC) curve for the Impact of Event Scale (IES) score in relation to the study outcome. The AUC was 0.51, showing minimal standalone discriminatory performance.